Dallas, Texas (PRWEB) May 20, 2013
The main objective for the present report is to present the up-to-date market picture for proteomics into a single comprehensive report. The objective was to capture the changing industry dynamics and market shift occurring in this industry. Thus, it is timely to examine the key aspects of the proteomic industry.
There is also an urgent need in the life science industry for technologies and products that can analyze and study the human proteome in a high-throughput, multiplex and low-cost way. Proteomic technologies are evolving to meet more of these needs, so it is important to keep abreast of these dynamics.
This report is intended to inform companies in the life science industries regarding the important trends in MS, LOAC and arrays, as well as to provide detailed information concerning the individual market segments and industry dynamics.
The goal for this study “Proteomics: Technologies and Global Markets” was to determine the status of proteomic technologies and products and assess their global growth potential over the five-year period from 2012 to 2017. The market was analyzed for the main proteomic platforms: mass spectrometry and biochips.
The biochip market was characterized by key biochip type (i.e., lab-on-a-chip, planar array, bead array) and by end-use industry (e.g., research, drug discovery and development, diagnostics, applied).
The mass spectrometry (MS) market was characterized by MS instrument type and end-use industry, as well as by MS workflow (e.g., sample preparation, chromatography, tagging and labeling reagents, and informatics).
A particular focus of the study is placed on the market for proteomic-based diagnostics products, which highlights a major future market segment for proteomic technologies.
The key objective was to present a comprehensive discussion of the main commercial proteomic technologies, along with the current and future commercial potential for each of the key market segments.
Scope and Format
The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays and LOAC. It also covers the research, drug discovery and development, diagnostics and applied end-user market segments. The main geographical markets—North America, Europe, Japan and Rest of World (ROW)—are included.
The MS market is covered by instrument type, MS consumables, product type and end-user markets. The biochip market is covered by biochip type and the-end user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication.
This report provides the current market sizes for these segments, as well as their forecasted growth through 2017.
Technology status and market driving forces are discussed. Factors that influence each market are also discussed, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.
Key industry acquisitions and strategic alliances are given for the three-year period from 2010 through 2012.
This report also examines the main patent trends within the industry and profiles 83 companies.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=247340.
Explore more reports on http://www.reportsnreports.com/market-research/biotechnology/.
ReportsnReports.com is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.
Read the full story at http://www.prweb.com/releases/proteomics-market-mass/spectrometry-and-biochips/prweb10749560.htm.
Copyright©2012 Vocus, Inc.
All rights reserved